Idebenone attenuates neuronal degeneration induced by excitotoxins

Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins.

Miyamoto M, Coyle JT.

Department of Psychiatry,
Johns Hopkins University School of Medicine,
Baltimore, Maryland 21205.
Exp Neurol 1990 Apr;108(1):38-45

ABSTRACT

Previous studies with the N18-RE-105 neuronal-like cell line and primary cortical cultures demonstrate that glutamate can produce a calcium-dependent, delayed form of neuronal degeneration that results from its competitive inhibition of cystine transport, which leads to cellular glutathione depletion and death by oxidative stress. Idebenone, a centrally active antioxidant used to treat multiinfarct dementia, protects cells from this form of glutamate-induced cytotoxicity in vitro. In the present study, we have examined the effects of systemic treatment with idebenone on the neurotoxic consequences of intrastriatal injection of kainic acid, quisqualic acid, or quinolinic acid, an NMDA receptor agonist, on neuronal degeneration. Striatal damage was assessed by quantitative neurochemistry with measurement of choline acetyltransferase activity and glutamate decarboxylase activity, by histochemical analysis for acetylcholinesterase and NADPH diaphorase staining and by behavioral assessment of circling produced by systemic apomorphine treatment 10 days after the unilateral lesion. The results indicate that treatment with idebenone provides significant protection against the neuronal degeneration induced by intrastriatal injection of kainic acid and quisqualic acid, but not the NMDA receptor agonist, quinolinic acid. The results suggest that oxidative stress may contribute to the proximate cause of neuronal degeneration induced by quisqualate and by kainate receptor agonists and that the mechanisms of neuronal degeneration caused by quisqualate/kainate receptor agonists differ from those associated with NMDA receptor agonists.

Idebenone - the ultimate anti-aging drug. (article)

Alzheimer's disease
Idebenone  in the treatment of Alzheimer's disease
Idebenone efficacy of idebenone in the treatment of Alzheimer's disease
Idebenone Nerve Growth Factor synthesis stimulators in Alzheimer's disease
Idebenone in the treatment of dementia of the Alzheimer type
Idebenone cognitive enhancement therapy for Alzheimer's disease

MELAS
Idebenone improves cerebral mitochondrial oxidative metabolism in MELAS
Idebenone in young patients with mitochondrial encephalomyopathy (MELAS)
Idebenone therapy in Mitochondrial encephalomyopathy (MELAS)
Idebenone and Mitochondrial encephalomyopathy (MELAS)
Idebenone successful therapy with idebenone in Mitochondrial encephalomyopathy (MELAS)
.
Cardiomyopathy
Idebenone improvement in mitochondrial cardiomyopathy following treatment with idebenone
Idebenone   effect of idebenone on cardiomyopathy in Friedreich's ataxia
.
Leber hereditary optic neuropathy (LHON)
Idebenone does it shorten the time to visual recovery in Leber hereditary optic neuropathy?
Idebenone improvement in a patient with Leber's hereditary optic neuropathy (LHON)

Misc.
Idebenone use in age-related cognitive disorders

Idebenone protects hippocampal neurons against beta amyloid neurotoxicity

Idebenone functions as a potent protective hepatocyte antioxidant

Idebenone neuroprotective effects of idebenone can be attributed to its antioxidant ability

Idebenone inhibition of brain mitochondrial swelling

Idebenone suppression of cold ischemia/reperfusion injury of liver endothelium

Idebenone ability to eliminate a nitroxide radical in the rat

Idebenone interaction with respiratory complexes of heart mitochondria

Idebenone effect on serotonin release and seroton receptors in rats

Idebenone protects hepatic microsomes against damage in organ preservation solutions

Idebenone protects against toxicity induced by low density lipoprotein

Idebenone protects against disorders due to cerebral hypoxia or ischemia

Idebenone protects against toxicity induced by low density lipoprotein

Idebenone attenuates neuronal degeneration induced by excitotoxins

Idebenone augments long-term potentiation in hippocampal slices in the guinea pig

Idebenoneeffects on lipid peroxidation in erythrocytes of stroke-prone, hypertensive rats

Idebenone brain distribution and its effect on local cerebral glucose utilization in rats

Idebenone effects on acetylcholine levels in the brains of rats with cerebral ischemia

Idebenone protective effect of idebenone against hypoxia in mice

Idebenone improves learning and memory impairment induced in rats

Idebenone effects of idebenone on neurological deficits in stroke-prone rats

Idebenone effects on memory induced impairment in rats

Idebenone effects of idebenone on cerebral blood flow in rats with cerebral ischemia

Idebenone inhibition of brain mitochondrial swelling by idebenone

Idebenone inhibition of platelet aggregation by idebenone

Idebenone effects of idebenone on monoamine metabolites of patients with dementia

Idebenone effects of idebenone on metabolism of monoamines and cyclic AMP formation

Idebenone effects on impairment of radial maze learning in cerebral embolized rats

Idebenone effect of idebenone on lipid peroxidation in rat brain homogenate

Idebenone effects on muricidal behavior in rats with raphe lesions

Idebenone inhibitory effect of idebenone on vascular lesions in hypertensive rats

Hit Counter